← Back to Search

Behavioural Intervention

Guided Digital Mindfulness Programs for Brain Health (BRIGHT-Mind Trial)

N/A
Recruiting
Led By Kevin Madore, PhD
Research Sponsored by Lumos Labs, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study day 0 to study day 84
Awards & highlights

BRIGHT-Mind Trial Summary

This trial looks at how digital programs can help improve mental health through improved thinking and brain changes.

Who is the study for?
This trial is for adults aged 25-80 who can use a computer with internet and video conferencing tools, understand English, and follow instructions. They must be able to see well enough (with glasses if needed) to work on a computer but cannot have had seizures or significant tics, severe mental health conditions, neurological disorders like Alzheimer's or Parkinson's, or any recent medical condition that could affect the study results. They should live independently and not be pregnant.Check my eligibility
What is being tested?
The study tests two digital programs designed to stimulate the mind. It aims to improve thinking skills and measure changes in brain structure and function through daily online activities participants complete at home using their own computers.See study design
What are the potential side effects?
Since this trial involves digital programs for cognitive stimulation rather than medication, traditional side effects are not expected. However, individuals sensitive to bright screens may experience headaches, dizziness or nausea.

BRIGHT-Mind Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study day 0 to study day 84
This trial's timeline: 3 weeks for screening, Varies for treatment, and study day 0 to study day 84 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Overall Composite from Creyos (formerly Cambridge Brain Sciences)
Secondary outcome measures
Concentration Domain Score from Creyos
Memory Domain Score from Creyos
Planning Domain Score from Creyos
+4 more

BRIGHT-Mind Trial Design

2Treatment groups
Experimental Treatment
Group I: Cohort BExperimental Treatment2 Interventions
Remote + Imaging subjects
Group II: Cohort AExperimental Treatment2 Interventions
Remote-Only subjects

Find a Location

Who is running the clinical trial?

Lumos Labs, Inc.Lead Sponsor
14 Previous Clinical Trials
15,402 Total Patients Enrolled
Kevin Madore, PhDPrincipal InvestigatorLumos Labs, Inc.
1 Previous Clinical Trials
40 Total Patients Enrolled

Media Library

Digital Program 1 (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05912556 — N/A
Cognition Research Study Groups: Cohort A, Cohort B

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any qualifications needed to participate in this trial?

"This medical trial is accepting 834 participants who are of the age range 25 to 80 and possess sound mental faculties."

Answered by AI

Are opportunities currently available to individuals seeking enrollment in this experiment?

"According to clinicaltrials.gov, this specific trial is not currently enrolling patients. Initially posted on June 16th 2023 and updated a few days later, 32 other trials are actively searching for eligible volunteers at the moment."

Answered by AI

Is the age threshold for participants in this experiment over thirty?

"This research is seeking individuals aged between 25 and 80 years old."

Answered by AI

Who else is applying?

What site did they apply to?
Lumos Labs, Inc.
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I'm diagnosed with ADHD and iterested in how my brain function and cognition differs from other individuals.
PatientReceived 1 prior treatment
~152 spots leftby Jul 2024